Cargando…
Metformin, Empagliflozin, and Their Combination Modulate Ex-Vivo Macrophage Inflammatory Gene Expression
Type-2 Diabetes Mellitus is a complex, chronic illness characterized by persistent high blood glucose levels. Patients can be prescribed anti-diabetes drugs as single agents or in combination depending on the severity of their condition. Metformin and empagliflozin are two commonly prescribed anti-d...
Autores principales: | Arefin, Adittya, Gage, Matthew C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10003317/ https://www.ncbi.nlm.nih.gov/pubmed/36902218 http://dx.doi.org/10.3390/ijms24054785 |
Ejemplares similares
-
Efficacy and safety of combination of empagliflozin and metformin with combination of sitagliptin and metformin during Ramadan: an observational study
por: Ahmed, Ibrar, et al.
Publicado: (2022) -
Empagliflozin-Metformin Combination Has Antioxidative and Anti-Inflammatory Properties that Correlate with Vascular Protection in Adults with Type 1 Diabetes
por: Janić, Miodrag, et al.
Publicado: (2022) -
Addressing child protection issues in Bangladesh's Rohingya and host community to improve children's health
por: Sultana, Zeeba Zahra, et al.
Publicado: (2022) -
Metabolic Hormones Modulate Macrophage Inflammatory Responses
por: Batty, Matthew J., et al.
Publicado: (2021) -
Combination of Empagliflozin and Metformin Therapy: A Consideration of its Place in Type 2 Diabetes Therapy
por: Goldman, Jennifer D
Publicado: (2018)